Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATP6V0E1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RHOF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NDUFC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIGD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
E2F4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKAB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT61A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDIPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on